Abstract
The aim of this study was to evaluate the psychometric properties of the Korean version of the European Organization for Research and Treatment of Cancer Breast-Cancer-Specific Quality of Life Questionnaire (EORTC QLQ-BR23). A total of 153 patients with breast cancer and 153 normal subjects completed three questionnaires of the Korean version of the EORTC QLQ-BR23. Multitrait scaling analyses demonstrated that all scales met multidimensional conceptualization criteria in terms of convergence and discrimination validity. Cronbach’s alpha coefficients for five multiple-item scales were greater than 0.70 (range, 0.72–0.91). In known-group comparisons, there were marked group differences between patients differing in disease stage. In breast cancer patients, performance on the questionnaires was in the expected direction for almost all functioning and symptom scores. In addition, comparison between the patient and control groups showed that almost all variables discriminated between patients and normal individuals. In conclusion, the Korean version of the EORTC QLQ-BR23 was found to be a reliable and valid measure of quality of life in breast cancer patients, indicating that it should be used in clinical and epidemiological cancer research.
Access this article
We’re sorry, something doesn't seem to be working properly.
Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.
Similar content being viewed by others
References
Bowling A (1995) What things are important in people’s lives? A survey of the public’s judgements to inform scales of health related quality of life. Soc Sci Med 41:1447–1462
Brady MJ, Cella DF, Mo F, et al (1997) Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument. J Clin Oncol 15:974–986
Cella DF, Tulsky DS, Gray G, et al (1993) The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 11:570–579
Cronbach LJ (1951) Coeffecient alpha and the internal structure of tests. Psychomrtrika 16:297–334
Fayers P, Aaronson N, Bjordal K, Sullivan M (1995) EORTC-C30 scoring manual. EORTC study group on quality of life, Brussels
Levine MN, Guyatt GH, Gent M, et al (1988) Quality of life in stage II breast cancer: an instrument for clinical trials. J Clin Oncol 6:1798–1810
Love RR, Leventhal H, Easterling DV, Nerenz DR (1989) Side effects and emotional distress during cancer chemotherapy. Cancer 63:604–612
Macleod CM (ed) (1949) Evaluation of chemotherapeutic agents. Columbia University Press, New York
Montazeri A, Harirchi I, Vahdani M, et al (2000) The EORTC breast cancer-specific quality of life questionnaire (EORTC QLQ-BR23): translation and validation study of the Iranian version. Qual Life Res 9:177–184
Nunnally JC (1994) Psychometric theory. McGraw-Hill, New York
Shin HR, et al (2002) Cancer incidence in Korea. Cancer research and treatment 34(6):405–408
Sprangers MA, Groenvold M, Arraras JI, et al (1996) The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol 14:2756–2768
Stewart BW and Kleihues P (eds) (2003) World cancer report. IARC Press. World Health Organization. Lyon, France
Zubord CG, Scheiderman MA, Frei E (1960) Appraisal of methods for the study of chemotherapy in man: comparative therapeutic trial of nitrogen mustard and triethylene thiopphosphoramide. J Chro Dis 11:7–33
Acknowledgements
This work was supported by a National Cancer Center Grant (0110030–3). We thank the EORTC Study Group on Quality of Life for their permission to translate the EORTC QLQ-BR23. We are especially grateful for the help received from Ms. Karen West of the EORTC Quality of Life Unit.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yun, Y.H., Bae, S.H., Kang, I.O. et al. Cross-cultural application of the Korean version of the European Organization for Research and Treatment of Cancer (EORTC) Breast-Cancer-Specific Quality of Life Questionnaire (EORTC QLQ-BR23). Support Care Cancer 12, 441–445 (2004). https://doi.org/10.1007/s00520-004-0632-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-004-0632-3